Teva to appeal EU antitrust sanction over MS drug
MLex Summary: Teva Pharmaceuticals has said it will appeal to the EU courts to overturn a European Commission fine related to its multiple-sclerosis drug Copaxone. The EU antitrust authority imposed a...To view the full article, register now.
Already a subscriber? Click here to view full article